SUPLEXACELLS
Dead / Abandoned — Abandoned — no statement of use filed (as of 19 Jun 2023)
What this means for you
This application is over — abandoned 19 Jun 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88643939
- Mark type
- Stylized text
- Filed
- 06 Oct 2019
- Published for opposition
- 24 Mar 2020
- Abandoned
- 19 Jun 2023
- Attorney of record
- Kelly J. Garrone
Goods and services
- Class 005 — Pharmaceuticals: Stimulated autologous blood cells for medical use for the treatment of cancer
- Class 044 — Medical, beauty and agricultural services: medical services, namely, cell therapy services involving use of stimulated autologous blood cells for the treatment of cancer
Owner
- Alloplex Biotherapeutics, Inc., Winchester, MA, US
- Alloplex Biotherapeutics, Inc., Winchester, MA, US
Prosecution history
- 20 Jun 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 19 Jun 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 27 Oct 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Oct 2022 — SOU EXTENSION 5 GRANTED
- 18 Oct 2022 — SOU EXTENSION 5 FILED
- 26 Oct 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Oct 2022 — SOU TEAS EXTENSION RECEIVED
- 16 Apr 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Apr 2022 — SOU EXTENSION 4 GRANTED
- 14 Apr 2022 — SOU EXTENSION 4 FILED
- 14 Apr 2022 — SOU TEAS EXTENSION RECEIVED
- 03 Nov 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Nov 2021 — SOU EXTENSION 3 GRANTED
- 01 Nov 2021 — SOU EXTENSION 3 FILED
- 01 Nov 2021 — SOU TEAS EXTENSION RECEIVED